35 related articles for article (PubMed ID: 31465767)
1. Excess Protein O-GlcNAcylation Links Metabolic Derangements to Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
Prisco SZ; Rose L; Potus F; Tian L; Wu D; Hartweck L; Al-Qazazi R; Neuber-Hess M; Eklund M; Hsu S; Thenappan T; Archer SL; Prins KW
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019763
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Hypertension-Associated Right Ventricular Cardiomyocyte Remodelling Reduces Treprostinil Function.
Judina A; Niglas M; Leonov V; Kirkby NS; Diakonov I; Wright PT; Zhao L; Mitchell JA; Gorelik J
Cells; 2023 Dec; 12(23):. PubMed ID: 38067192
[TBL] [Abstract][Full Text] [Related]
3. Postnatal Hyperoxia Exposure Durably Impairs Right Ventricular Function and Mitochondrial Biogenesis.
Goss KN; Kumari S; Tetri LH; Barton G; Braun RK; Hacker TA; Eldridge MW
Am J Respir Cell Mol Biol; 2017 May; 56(5):609-619. PubMed ID: 28129517
[TBL] [Abstract][Full Text] [Related]
4. Protective Effect of Triclosan in Monocrotaline-Induced Pulmonary Arterial Hypertension: FASN Inhibition a Novel Approach.
Alsabeelah N; Kumar V
J Pharm Bioallied Sci; 2022; 14(4):171-177. PubMed ID: 37051426
[TBL] [Abstract][Full Text] [Related]
5. Serum Metabolomic Profile in Hypoxia-Induced Pulmonary Hypertension Mice after C75 Treatment.
Chen S; Lin S; Liu W; Lin Q; Yang Y; Qiu Q; Zong Y; Xiao T; Hou C; Xie L
Front Biosci (Landmark Ed); 2023 Oct; 28(10):251. PubMed ID: 37919066
[TBL] [Abstract][Full Text] [Related]
6. 17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelin.
Frump AL; Albrecht M; Yakubov B; Breuils-Bonnet S; Nadeau V; Tremblay E; Potus F; Omura J; Cook T; Fisher A; Rodriguez B; Brown RD; Stenmark KR; Rubinstein CD; Krentz K; Tabima DM; Li R; Sun X; Chesler NC; Provencher S; Bonnet S; Lahm T
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497359
[TBL] [Abstract][Full Text] [Related]
7. Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review.
Xiao Y; Chen PP; Zhou RL; Zhang Y; Tian Z; Zhang SY
Aging Dis; 2020 Dec; 11(6):1623-1639. PubMed ID: 33269111
[TBL] [Abstract][Full Text] [Related]
8. Identification of Zip8-correlated hub genes in pulmonary hypertension by informatic analysis.
Zhao F; Chen Y; Xie Y; Kong S; Song L; Li H; Guo C; Yin Y; Zhang W; Zhu T
PeerJ; 2023; 11():e15939. PubMed ID: 37663293
[TBL] [Abstract][Full Text] [Related]
9. Role of macrophages in pulmonary arterial hypertension.
Zhang MQ; Wang CC; Pang XB; Shi JZ; Li HR; Xie XM; Wang Z; Zhang HD; Zhou YF; Chen JW; Han ZY; Zhao LL; He YY
Front Immunol; 2023; 14():1152881. PubMed ID: 37153557
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty acid synthase protects obese mice from acute lung injury via ameliorating lung endothelial dysfunction.
Wu Z; Zhu L; Nie X; Liu Y; Zhang X; Qi Y
Respir Res; 2023 Mar; 24(1):81. PubMed ID: 36922854
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of Fatty Acid Synthase in Hypoxia-Induced Pulmonary Hypertensive Mouse Energy Metabolism.
Hou C; Chen J; Zhao Y; Niu Y; Lin S; Chen S; Zong Y; Sun X; Xie L; Xiao T
Oxid Med Cell Longev; 2021; 2021():9990794. PubMed ID: 34457121
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive activity of oleanolic acid is mediated via downregulation of secretory phospholipase A2 and fatty acid synthase in spontaneously hypertensive rats.
Zhang S; Liu Y; Wang X; Tian Z; Qi D; Li Y; Jiang H
Int J Mol Med; 2020 Dec; 46(6):2019-2034. PubMed ID: 33125128
[TBL] [Abstract][Full Text] [Related]
13. Involvement of fatty acid synthase in right ventricle dysfunction in pulmonary hypertension.
Singh N; Shafiq M; Jagavelu K; Hanif K
Exp Cell Res; 2019 Oct; 383(2):111569. PubMed ID: 31465767
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of fatty acid synthase is protective in pulmonary hypertension.
Singh N; Manhas A; Kaur G; Jagavelu K; Hanif K
Br J Pharmacol; 2016 Jun; 173(12):2030-45. PubMed ID: 27061087
[TBL] [Abstract][Full Text] [Related]
15. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
16. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.
Gomez-Arroyo J; Mizuno S; Szczepanek K; Van Tassell B; Natarajan R; dos Remedios CG; Drake JI; Farkas L; Kraskauskas D; Wijesinghe DS; Chalfant CE; Bigbee J; Abbate A; Lesnefsky EJ; Bogaard HJ; Voelkel NF
Circ Heart Fail; 2013 Jan; 6(1):136-44. PubMed ID: 23152488
[TBL] [Abstract][Full Text] [Related]
17. Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.
Maarman GJ; Schulz R; Sliwa K; Schermuly RT; Lecour S
Br J Pharmacol; 2017 Apr; 174(7):497-511. PubMed ID: 28099680
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid metabolism in pulmonary arterial hypertension: role in right ventricular dysfunction and hypertrophy.
Talati M; Hemnes A
Pulm Circ; 2015 Jun; 5(2):269-78. PubMed ID: 26064451
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
